RQM+, a leading global MedTech clinical research organisation (CRO), has announced it will attend the World Health Expo as part of the UK Pavilion, where it will showcase its comprehensive, end-to-end support for medical device and diagnostics companies across the full product life cycle.
As The MedTech CRO, RQM+ partners with both pioneering innovators and established organisations, delivering coordinated clinical, regulatory, quality and laboratory solutions tailored to each product’s stage of development. By aligning strategy and execution within a single partner, the company helps reduce costs, accelerate timelines and drive stronger outcomes for clients bringing technologies to market.
With more than 40 years of regulatory expertise and a strong track record across the U.S. and Europe, RQM+ supports organisations in navigating complex compliance requirements while ensuring clinical trials remain efficient, safe and fully compliant. Its integrated capabilities also span reimbursement strategy, material and chemical characterisation, and advanced scientific consulting, helping ensure products meet global standards and reach patients effectively.
“We don’t build medical devices, we make sure they meet global standards. We don’t invent life-changing diagnostics, we help make them accessible to patients,” said Tim Berry. Senior Director Business Development at RQM+.
"By combining regulatory, clinical, quality and scientific expertise in one connected approach, we support MedTech innovators at every stage, helping them move from concept to commercial success with confidence.”
RQM+ has completed more than 5,000 consulting projects and delivered over 1,300 studies worldwide, supporting more than 1,000 clients. The company also draws on specialist laboratory capabilities through Jordi Labs to strengthen product safety, performance and compliance.
